Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+7.65%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$8.27B
AUM Growth
+$1.17B
(+17%)
Cap. Flow
+$750M
Cap. Flow
% of AUM
9.07%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$287M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$258M |
| 3 |
Apple
AAPL
|
$67.9M |
| 4 |
Microsoft
MSFT
|
$62.7M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$59.7M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$189M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$112M |
| 3 |
Visa
V
|
$56.8M |
| 4 |
Mastercard
MA
|
$50M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$42.1M |
Sector Composition
| 1 | Technology | 27.51% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 4.08% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWTR
576
DELISTED
Twitter, Inc.
TWTR
| $1.05M | 0.01% |
23,503
+8,941
| +61% | +$398K |
|
577
SLM Corp
SLM
$6.49B
| $1.05M | 0.01% |
129,226
+52,196
| +68% | +$422K |
|
578
MGIC Investment
MTG
$6.55B
| $1.03M | 0.01% |
116,599
+47,093
| +68% | +$417K |
|
579
Southern Company
SO
$101B
| $1.03M | 0.01% |
18,950
-8,604
| -31% | -$466K |
|
580
HF Sinclair
DINO
$9.56B
| $1M | 0.01% |
50,717
-5,205
| -9% | -$103K |
|
581
Carlyle Group
CG
$23.1B
| $992K | 0.01% |
40,214
+16,157
| +67% | +$399K |
|
582
Boston Scientific
BSX
$159B
| $987K | 0.01% |
25,820
-6,282
| -20% | -$240K |
|
583
IPG Photonics
IPGP
$3.56B
| $963K | 0.01% |
5,667
-3,216
| -36% | -$546K |
|
|
VIE
584
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $943K | 0.01% |
33,566
+28,544
| +568% | +$802K |
|
|
BECN
585
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $929K | 0.01% |
29,909
-2,437
| -8% | -$75.7K |
|
|
MAXR
586
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $929K | 0.01% |
+37,254
| New | +$929K |
|
587
Atara Biotherapeutics
ATRA
$90.7M
| $924K | 0.01% |
2,853
+1,408
| +97% | +$456K |
|
588
Puma Biotechnology
PBYI
$253M
| $903K | 0.01% |
89,529
+40,557
| +83% | +$409K |
|
589
Bankunited
BKU
$2.93B
| $894K | 0.01% |
40,806
+2,458
| +6% | +$53.9K |
|
590
Evercore
EVR
$12.3B
| $892K | 0.01% |
13,630
+5,503
| +68% | +$360K |
|
591
Viking Therapeutics
VKTX
$3.03B
| $888K | 0.01% |
152,640
+100,155
| +191% | +$583K |
|
592
Welltower
WELL
$112B
| $885K | 0.01% |
16,056
-83,624
| -84% | -$4.61M |
|
593
Bio-Rad Laboratories Class A
BIO
$8B
| $877K | 0.01% |
1,702
+1,220
| +253% | +$629K |
|
594
Kura Oncology
KURA
$713M
| $876K | 0.01% |
28,605
+16,111
| +129% | +$493K |
|
|
KDMN
595
DELISTED
Kadmon Holdings, Inc.
KDMN
| $872K | 0.01% |
222,328
+148,302
| +200% | +$582K |
|
596
SouthState Bank Corporation
SSB
$10.4B
| $870K | 0.01% |
18,070
+6,383
| +55% | +$307K |
|
597
Brighthouse Financial
BHF
$2.48B
| $863K | 0.01% |
32,083
+11,848
| +59% | +$319K |
|
598
Weyerhaeuser
WY
$18.9B
| $855K | 0.01% |
29,991
-161,021
| -84% | -$4.59M |
|
599
Rocket Pharmaceuticals
RCKT
$354M
| $842K | 0.01% |
36,822
+21,975
| +148% | +$502K |
|
600
DXC Technology
DXC
$2.65B
| $837K | 0.01% |
46,876
+398
| +0.9% | +$7.11K |
|